AbbVie
ABBV
#25
Rank
โ‚น48.691 T
Marketcap
โ‚น27,546
Share price
0.68%
Change (1 day)
42.10%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of June 2026 : โ‚น6.651 Trillion

According to AbbVie's latest financial reports the company's total debt is โ‚น6.651 Trillion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚น6.059 T5.19%
2024-12-31โ‚น5.760 T16.51%
2023-12-31โ‚น4.943 T-5.58%
2022-12-31โ‚น5.235 T-8.27%
2021-12-31โ‚น5.707 T-9.31%
2020-12-31โ‚น6.293 T32.26%
2019-12-31โ‚น4.758 T68.82%
2018-12-31โ‚น2.818 T18.13%
2017-12-31โ‚น2.385 T-4.7%
2016-12-31โ‚น2.503 T18.95%
2015-12-31โ‚น2.104 T121.73%
2014-12-31โ‚น949.21 B4.36%
2013-12-31โ‚น909.58 B6%
2012-12-31โ‚น858.08 B33693.67%
2011-12-31โ‚น2.53 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚น5.935 T-10.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น4.649 T-30.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น5.381 T-19.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น784.69 B-88.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.464 T-62.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.208 T-36.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น3.027 T-54.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น2.952 T-55.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น37.73 B-99.43%๐Ÿ‡บ๐Ÿ‡ธ USA